| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| - - | HOLD | 0 @ USD 0 | USD 0 | The current share valuation price of - based on adjusted close was USD 0. The average price that - shares were previous bought at was USD 0.00279608. The current market price is -100.0% lower than average price they were purchased at. USD 0 compared to the previous valuation of however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| 182400.KQ - NKMAX LTD | HOLD | 0 @ KRW 3.89607 | KRW 0 | |
| MRUS - Merus BV | HOLD | 0 @ USD 97.01 | USD 0 | The current share valuation price of MRUS based on adjusted close was USD 97.01. The average price that MRUS shares were previous bought at was USD 56.564. The current market price is 71.5% higher than average price they were purchased at. The value of the holding in MRUS has increased by USD 16,261 compared to the previous valuation of Merus BV however if the holding was sold on 2025-12-19 this would crystalise an overall loss. |
| ARCT - Arcturus Therapeutics Holdings Inc | SELL | -620 @ USD 6.52999 | USD -4,049 | The ETF sold 620 shares of ARCT on 2025-12-19. The shares were previously bought for an average price of USD 13.0207. The Arcturus Therapeutics Holdings Inc shares were sold for -49.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,024 The average price that the ETF previously sold ARCT share for is USD 13.0245 which is higher than the selling price of USD 6.52999 on 2025-12-19. |
| 4974.T - Takara Bio Inc. | SELL | -1,500 @ JPY 4.93411 | JPY -7,401 | The ETF sold 1500 shares of 4974.T on 2025-12-19. The shares were previously bought for an average price of JPY 5.75157. The Takara Bio Inc. shares were sold for -14.2% lower than average price of previous purchases. This resulted in an overall loss of JPY 1,226 The average price that the ETF previously sold 4974.T share for is JPY 5.80778 which is higher than the selling price of JPY 4.93411 on 2025-12-19. |
| 4549.T - Eiken Chemical Co., Ltd. | SELL | -500 @ JPY 15.4755 | JPY -7,738 | The ETF sold 500 shares of 4549.T on 2025-12-19. The shares were previously bought for an average price of JPY 13.728. The Eiken Chemical Co., Ltd. shares were sold for 12.7% higher than average price of previous purchases. This sale made a profit of JPY 874 The average price that the ETF previously sold 4549.T share for is JPY 14.3381 so the ETF has sold 500 shares on 2025-12-19 at a higher price than the previous selling average. |
| SLP - Sylvania Platinum Limited | SELL | -420 @ USD 18.75 | USD -7,875 | The ETF sold 420 shares of SLP on 2025-12-19. The shares were previously bought for an average price of USD 26.1345. The Sylvania Platinum Limited shares were sold for -28.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,101 The average price that the ETF previously sold SLP share for is USD 26.8306 which is higher than the selling price of USD 18.75 on 2025-12-19. |
| VNDA - Vanda Pharmaceuticals Inc | SELL | -1,540 @ USD 6.75 | USD -10,395 | The ETF sold 1540 shares of VNDA on 2025-12-19. The shares were previously bought for an average price of USD 4.65578. The Vanda Pharmaceuticals Inc shares were sold for 45.0% higher than average price of previous purchases. This sale made a profit of USD 3,225 The average price that the ETF previously sold VNDA share for is USD 4.63014 so the ETF has sold 1540 shares on 2025-12-19 at a higher price than the previous selling average. |
| EVH - Evolent Health Inc | SELL | -2,880 @ USD 3.99 | USD -11,491 | The ETF sold 2880 shares of EVH on 2025-12-19. The shares were previously bought for an average price of USD 9.55347. The Evolent Health Inc shares were sold for -58.2% lower than average price of previous purchases. This resulted in an overall loss of USD 16,023 The average price that the ETF previously sold EVH share for is USD 10.5994 which is higher than the selling price of USD 3.99 on 2025-12-19. |
| 1877.HK - SHANGHAI JUNSHI BIOSCIENCES LTD H | SELL | -4,000 @ HKD 2.98619 | HKD -11,945 | The ETF sold 4000 shares of 1877.HK on 2025-12-19. The shares were previously bought for an average price of HKD 2.51798. The SHANGHAI JUNSHI BIOSCIENCES LTD H shares were sold for 18.6% higher than average price of previous purchases. This sale made a profit of HKD 1,873 The average price that the ETF previously sold 1877.HK share for is HKD 2.03721 so the ETF has sold 4000 shares on 2025-12-19 at a higher price than the previous selling average. |
| MRVI - Maravai Lifesciences Holdings Inc | SELL | -3,545 @ USD 3.43 | USD -12,159 | The ETF sold 3545 shares of MRVI on 2025-12-19. The shares were previously bought for an average price of USD 2.97559. The Maravai Lifesciences Holdings Inc shares were sold for 15.3% higher than average price of previous purchases. This sale made a profit of USD 1,611 The average price that the ETF previously sold MRVI share for is USD 3.38785 so the ETF has sold 3545 shares on 2025-12-19 at a higher price than the previous selling average. |
| IBRX - Immunitybio Inc | SELL | -6,215 @ USD 2.08 | USD -12,927 | The ETF sold 6215 shares of IBRX on 2025-12-19. The shares were previously bought for an average price of USD 2.81966. The Immunitybio Inc shares were sold for -26.2% lower than average price of previous purchases. This resulted in an overall loss of USD 4,597 The average price that the ETF previously sold IBRX share for is USD 3.27775 which is higher than the selling price of USD 2.08 on 2025-12-19. |
| XVIVO.ST - | SELL | -660 @ SEK 20.238 | SEK -13,357 | The ETF sold 660 shares of XVIVO.ST on 2025-12-19. The shares were previously bought for an average price of SEK 40.1806. The shares were sold for -49.6% lower than average price of previous purchases. This resulted in an overall loss of SEK 13,162 The average price that the ETF previously sold XVIVO.ST share for is SEK 32.9127 which is higher than the selling price of SEK 20.238 on 2025-12-19. |
| PACB - Pacific Biosciences of California | SELL | -8,115 @ USD 1.84 | USD -14,932 | The ETF sold 8115 shares of PACB on 2025-12-19. The shares were previously bought for an average price of USD 1.37661. The Pacific Biosciences of California shares were sold for 33.7% higher than average price of previous purchases. This sale made a profit of USD 3,760 The average price that the ETF previously sold PACB share for is USD 1.52375 so the ETF has sold 8115 shares on 2025-12-19 at a higher price than the previous selling average. |
| 7575.T - Japan Lifeline Co., Ltd. | SELL | -1,500 @ JPY 10.0968 | JPY -15,145 | The ETF sold 1500 shares of 7575.T on 2025-12-19. The shares were previously bought for an average price of JPY 10.1423. The Japan Lifeline Co., Ltd. shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of JPY 68 The average price that the ETF previously sold 7575.T share for is JPY 9.55093 so the ETF has sold 1500 shares on 2025-12-19 at a higher price than the previous selling average. |
| LAB - Standard Biotools Inc | SELL | -9,330 @ USD 1.63 | USD -15,208 | The ETF sold 9330 shares of LAB on 2025-12-19. The shares were previously bought for an average price of USD 1.39779. The Standard Biotools Inc shares were sold for 16.6% higher than average price of previous purchases. This sale made a profit of USD 2,167 The average price that the ETF previously sold LAB share for is USD 1.34364 so the ETF has sold 9330 shares on 2025-12-19 at a higher price than the previous selling average. |
| VLA.PA - Valneva SE | SELL | -3,680 @ EUR 4.17344 | EUR -15,358 | The ETF sold 3680 shares of VLA.PA on 2025-12-19. The shares were previously bought for an average price of EUR 2.91512. The Valneva SE shares were sold for 43.2% higher than average price of previous purchases. This sale made a profit of EUR 4,631 The average price that the ETF previously sold VLA.PA share for is EUR 3.14046 so the ETF has sold 3680 shares on 2025-12-19 at a higher price than the previous selling average. |
| VIR - Vir Biotechnology Inc | SELL | -2,725 @ USD 5.76 | USD -15,696 | The ETF sold 2725 shares of VIR on 2025-12-19. The shares were previously bought for an average price of USD 7.32775. The Vir Biotechnology Inc shares were sold for -21.4% lower than average price of previous purchases. This resulted in an overall loss of USD 4,272 The average price that the ETF previously sold VIR share for is USD 6.48298 which is higher than the selling price of USD 5.76 on 2025-12-19. |
| VIR - Vidrala S.A | SELL | -2,725 @ USD 5.76 | USD -15,696 | The ETF sold 2725 shares of VIR on 2025-12-19. The shares were previously bought for an average price of USD 7.32775. The Vidrala S.A shares were sold for -21.4% lower than average price of previous purchases. This resulted in an overall loss of USD 4,272 The average price that the ETF previously sold VIR share for is USD 6.48298 which is higher than the selling price of USD 5.76 on 2025-12-19. |
| MYGN - Myriad Genetics Inc | SELL | -2,440 @ USD 6.55 | USD -15,982 | The ETF sold 2440 shares of MYGN on 2025-12-19. The shares were previously bought for an average price of USD 8.64702. The Myriad Genetics Inc shares were sold for -24.3% lower than average price of previous purchases. This resulted in an overall loss of USD 5,117 The average price that the ETF previously sold MYGN share for is USD 9.94796 which is higher than the selling price of USD 6.55 on 2025-12-19. |
| 096530.KQ - Seegene, Inc. | SELL | -970 @ KRW 16.6481 | KRW -16,149 | The ETF sold 970 shares of 096530.KQ on 2025-12-19. The shares were previously bought for an average price of KRW 17.6933. The Seegene, Inc. shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of KRW 1,014 The average price that the ETF previously sold 096530.KQ share for is KRW 20.809 which is higher than the selling price of KRW 16.6481 on 2025-12-19. |
| RO.SW - | SELL | -40 @ CHF 419.928 | CHF -16,797 | The ETF sold 40 shares of RO.SW on 2025-12-19. The shares were previously bought for an average price of CHF 370.354. The shares were sold for 13.4% higher than average price of previous purchases. This sale made a profit of CHF 1,983 The average price that the ETF previously sold RO.SW share for is CHF 333.116 so the ETF has sold 40 shares on 2025-12-19 at a higher price than the previous selling average. |
| RGNX - Regenxbio Inc | SELL | -1,190 @ USD 14.59 | USD -17,362 | The ETF sold 1190 shares of RGNX on 2025-12-19. The shares were previously bought for an average price of USD 8.67354. The Regenxbio Inc shares were sold for 68.2% higher than average price of previous purchases. This sale made a profit of USD 7,041 The average price that the ETF previously sold RGNX share for is USD 8.65328 so the ETF has sold 1190 shares on 2025-12-19 at a higher price than the previous selling average. |
| CTKB - Cytek Biosciences Inc | SELL | -3,520 @ USD 4.95 | USD -17,424 | The ETF sold 3520 shares of CTKB on 2025-12-19. The shares were previously bought for an average price of USD 5.7145. The Cytek Biosciences Inc shares were sold for -13.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,691 The average price that the ETF previously sold CTKB share for is USD 4.49205 so the ETF has sold 3520 shares on 2025-12-19 at a higher price than the previous selling average. |
| EMBC - Embecta Corp | SELL | -1,540 @ USD 11.75 | USD -18,095 | The ETF sold 1540 shares of EMBC on 2025-12-19. The shares were previously bought for an average price of USD 13.0183. The Embecta Corp shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,953 The average price that the ETF previously sold EMBC share for is USD 12.4599 which is higher than the selling price of USD 11.75 on 2025-12-19. |
| IOVA - Iovance Biotherapeutics Inc | SELL | -7,415 @ USD 2.48 | USD -18,389 | The ETF sold 7415 shares of IOVA on 2025-12-19. The shares were previously bought for an average price of USD 2.41138. The Iovance Biotherapeutics Inc shares were sold for 2.8% higher than average price of previous purchases. This sale made a profit of USD 509 The average price that the ETF previously sold IOVA share for is USD 4.68468 which is higher than the selling price of USD 2.48 on 2025-12-19. |
| DAWN - Day One Biopharmaceuticals Inc | SELL | -2,045 @ USD 9.24 | USD -18,896 | The ETF sold 2045 shares of DAWN on 2025-12-19. The shares were previously bought for an average price of USD 8.3429. The Day One Biopharmaceuticals Inc shares were sold for 10.8% higher than average price of previous purchases. This sale made a profit of USD 1,835 The average price that the ETF previously sold DAWN share for is USD 7.70082 so the ETF has sold 2045 shares on 2025-12-19 at a higher price than the previous selling average. |
| EUZ.DE - Eckert & Ziegler SE | SELL | -1,150 @ EUR 16.8273 | EUR -19,351 | The ETF sold 1150 shares of EUZ.DE on 2025-12-19. The shares were previously bought for an average price of EUR 18.7965. The Eckert & Ziegler SE shares were sold for -10.5% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,265 The average price that the ETF previously sold EUZ.DE share for is EUR 26.7186 which is higher than the selling price of EUR 16.8273 on 2025-12-19. |
| 328130.KQ - Lunit Inc. | SELL | -715 @ KRW 27.4084 | KRW -19,597 | The ETF sold 715 shares of 328130.KQ on 2025-12-19. The shares were previously bought for an average price of KRW 36.3011. The Lunit Inc. shares were sold for -24.5% lower than average price of previous purchases. This resulted in an overall loss of KRW 6,358 The average price that the ETF previously sold 328130.KQ share for is KRW 35.5451 which is higher than the selling price of KRW 27.4084 on 2025-12-19. |
| KURA - Kura Oncology Inc | SELL | -2,085 @ USD 9.84 | USD -20,516 | The ETF sold 2085 shares of KURA on 2025-12-19. The shares were previously bought for an average price of USD 10.711. The Kura Oncology Inc shares were sold for -8.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,816 The average price that the ETF previously sold KURA share for is USD 8.9454 so the ETF has sold 2085 shares on 2025-12-19 at a higher price than the previous selling average. |
| 007390.KQ - NatureCell Co.,Ltd. | SELL | -1,400 @ KRW 14.9562 | KRW -20,939 | The ETF sold 1400 shares of 007390.KQ on 2025-12-19. The shares were previously bought for an average price of KRW 21.4176. The NatureCell Co.,Ltd. shares were sold for -30.2% lower than average price of previous purchases. This resulted in an overall loss of KRW 9,046 The average price that the ETF previously sold 007390.KQ share for is KRW 17.6637 which is higher than the selling price of KRW 14.9562 on 2025-12-19. |
| JANX - Janux Therapeutics Inc | SELL | -1,530 @ USD 13.79 | USD -21,099 | The ETF sold 1530 shares of JANX on 2025-12-19. The shares were previously bought for an average price of USD 24.7281. The Janux Therapeutics Inc shares were sold for -44.2% lower than average price of previous purchases. This resulted in an overall loss of USD 16,735 The average price that the ETF previously sold JANX share for is USD 33.2294 which is higher than the selling price of USD 13.79 on 2025-12-19. |
| ARVN - Arvinas Inc | SELL | -1,875 @ USD 11.68 | USD -21,900 | The ETF sold 1875 shares of ARVN on 2025-12-19. The shares were previously bought for an average price of USD 11.3626. The Arvinas Inc shares were sold for 2.8% higher than average price of previous purchases. This sale made a profit of USD 595 The average price that the ETF previously sold ARVN share for is USD 12.9758 which is higher than the selling price of USD 11.68 on 2025-12-19. |
| ABCL - Abcellera Biologics Inc | SELL | -6,145 @ USD 3.6 | USD -22,122 | The ETF sold 6145 shares of ABCL on 2025-12-19. The shares were previously bought for an average price of USD 3.61385. The Abcellera Biologics Inc shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 85 The average price that the ETF previously sold ABCL share for is USD 2.73968 so the ETF has sold 6145 shares on 2025-12-19 at a higher price than the previous selling average. |
| IART - Integra LifeSciences Holdings | SELL | -1,790 @ USD 12.65 | USD -22,644 | The ETF sold 1790 shares of IART on 2025-12-19. The shares were previously bought for an average price of USD 20.1099. The Integra LifeSciences Holdings shares were sold for -37.1% lower than average price of previous purchases. This resulted in an overall loss of USD 13,353 The average price that the ETF previously sold IART share for is USD 18.4089 which is higher than the selling price of USD 12.65 on 2025-12-19. |
| AMLX - Amylyx Pharmaceuticals Inc | SELL | -1,965 @ USD 12.02 | USD -23,619 | The ETF sold 1965 shares of AMLX on 2025-12-19. The shares were previously bought for an average price of USD 13.5196. The Amylyx Pharmaceuticals Inc shares were sold for -11.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,947 The average price that the ETF previously sold AMLX share for is USD 10.6777 so the ETF has sold 1965 shares on 2025-12-19 at a higher price than the previous selling average. |
| 302440.KS - SK BIOSCIENCE LTD | SELL | -690 @ KRW 34.5143 | KRW -23,815 | The ETF sold 690 shares of 302440.KS on 2025-12-19. The shares were previously bought for an average price of KRW 36.2275. The SK BIOSCIENCE LTD shares were sold for -4.7% lower than average price of previous purchases. This resulted in an overall loss of KRW 1,182 The average price that the ETF previously sold 302440.KS share for is KRW 31.2898 so the ETF has sold 690 shares on 2025-12-19 at a higher price than the previous selling average. |
| EVT.DE - Evotec SE | SELL | -3,985 @ EUR 6.05407 | EUR -24,125 | The ETF sold 3985 shares of EVT.DE on 2025-12-19. The shares were previously bought for an average price of EUR 6.56761. The Evotec SE shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,046 The average price that the ETF previously sold EVT.DE share for is EUR 7.97214 which is higher than the selling price of EUR 6.05407 on 2025-12-19. |
| ASTH - Astrana Health Inc | SELL | -1,070 @ USD 23.87 | USD -25,541 | The ETF sold 1070 shares of ASTH on 2025-12-19. The shares were previously bought for an average price of USD 26.5685. The Astrana Health Inc shares were sold for -10.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,887 The average price that the ETF previously sold ASTH share for is USD 33.6313 which is higher than the selling price of USD 23.87 on 2025-12-19. |
| ONT.L - Oxford Nanopore Technologies Ltd | SELL | -15,225 @ GBP 1.68622 | GBP -25,673 | The ETF sold 15225 shares of ONT.L on 2025-12-19. The shares were previously bought for an average price of GBP 1.72772. The Oxford Nanopore Technologies Ltd shares were sold for -2.4% lower than average price of previous purchases. This resulted in an overall loss of GBP 632 The average price that the ETF previously sold ONT.L share for is GBP 1.61781 so the ETF has sold 15225 shares on 2025-12-19 at a higher price than the previous selling average. |
| 4587.T - PeptiDream Inc. | SELL | -2,500 @ JPY 10.5699 | JPY -26,425 | The ETF sold 2500 shares of 4587.T on 2025-12-19. The shares were previously bought for an average price of JPY 11.127. The PeptiDream Inc. shares were sold for -5.0% lower than average price of previous purchases. This resulted in an overall loss of JPY 1,393 The average price that the ETF previously sold 4587.T share for is JPY 10.7751 which is higher than the selling price of JPY 10.5699 on 2025-12-19. |
| CDNA - Caredx Inc | SELL | -1,365 @ USD 19.45 | USD -26,549 | The ETF sold 1365 shares of CDNA on 2025-12-19. The shares were previously bought for an average price of USD 19.212. The Caredx Inc shares were sold for 1.2% higher than average price of previous purchases. This sale made a profit of USD 325 The average price that the ETF previously sold CDNA share for is USD 19.52 which is higher than the selling price of USD 19.45 on 2025-12-19. |
| NVAX - Novavax Inc | SELL | -4,000 @ USD 6.66 | USD -26,640 | The ETF sold 4000 shares of NVAX on 2025-12-19. The shares were previously bought for an average price of USD 6.53102. The Novavax Inc shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of USD 516 The average price that the ETF previously sold NVAX share for is USD 7.22425 which is higher than the selling price of USD 6.66 on 2025-12-19. |
| NVAX - Hana Microelectronics Public Company Limited | SELL | -4,000 @ USD 6.66 | USD -26,640 | The ETF sold 4000 shares of NVAX on 2025-12-19. The shares were previously bought for an average price of USD 6.53102. The Hana Microelectronics Public Company Limited shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of USD 516 The average price that the ETF previously sold NVAX share for is USD 7.22425 which is higher than the selling price of USD 6.66 on 2025-12-19. |
| SDGR - Schrodinger Inc | SELL | -1,535 @ USD 17.66 | USD -27,108 | The ETF sold 1535 shares of SDGR on 2025-12-19. The shares were previously bought for an average price of USD 22.5384. The Schrodinger Inc shares were sold for -21.6% lower than average price of previous purchases. This resulted in an overall loss of USD 7,488 The average price that the ETF previously sold SDGR share for is USD 20.8353 which is higher than the selling price of USD 17.66 on 2025-12-19. |
| 2252.HK - SHANGHAI MICROPORT MEDBOT CLASS H | SELL | -10,000 @ HKD 2.76775 | HKD -27,678 | The ETF sold 10000 shares of 2252.HK on 2025-12-19. The shares were previously bought for an average price of HKD 3.16268. The SHANGHAI MICROPORT MEDBOT CLASS H shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of HKD 3,949 The average price that the ETF previously sold 2252.HK share for is HKD 2.71861 so the ETF has sold 10000 shares on 2025-12-19 at a higher price than the previous selling average. |
| ANAB - AnaptysBio Inc | SELL | -570 @ USD 49.08 | USD -27,976 | The ETF sold 570 shares of ANAB on 2025-12-19. The shares were previously bought for an average price of USD 23.8129. The AnaptysBio Inc shares were sold for 106.1% higher than average price of previous purchases. This sale made a profit of USD 14,402 The average price that the ETF previously sold ANAB share for is USD 22.0439 so the ETF has sold 570 shares on 2025-12-19 at a higher price than the previous selling average. |
| CERT - Certara Inc | SELL | -3,090 @ USD 9.07 | USD -28,026 | The ETF sold 3090 shares of CERT on 2025-12-19. The shares were previously bought for an average price of USD 10.4074. The Certara Inc shares were sold for -12.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,133 The average price that the ETF previously sold CERT share for is USD 10.8401 which is higher than the selling price of USD 9.07 on 2025-12-19. |
| 237690.KQ - ST Pharm Co.,Ltd. | SELL | -325 @ KRW 86.421 | KRW -28,087 | The ETF sold 325 shares of 237690.KQ on 2025-12-19. The shares were previously bought for an average price of KRW 55.5458. The ST Pharm Co.,Ltd. shares were sold for 55.6% higher than average price of previous purchases. This sale made a profit of KRW 10,034 The average price that the ETF previously sold 237690.KQ share for is KRW 59.1804 so the ETF has sold 325 shares on 2025-12-19 at a higher price than the previous selling average. |
| 039200.KQ - Oscotec Inc. | SELL | -880 @ KRW 33.1946 | KRW -29,211 | The ETF sold 880 shares of 039200.KQ on 2025-12-19. The shares were previously bought for an average price of KRW 21.0043. The Oscotec Inc. shares were sold for 58.0% higher than average price of previous purchases. This sale made a profit of KRW 10,727 The average price that the ETF previously sold 039200.KQ share for is KRW 30.3635 so the ETF has sold 880 shares on 2025-12-19 at a higher price than the previous selling average. |
| DYVOX.ST - | SELL | -2,710 @ SEK 10.9645 | SEK -29,714 | The ETF sold 2710 shares of DYVOX.ST on 2025-12-19. The shares were previously bought for an average price of SEK 6.29712. The shares were sold for 74.1% higher than average price of previous purchases. This sale made a profit of SEK 12,649 The average price that the ETF previously sold DYVOX.ST share for is SEK 7.46034 so the ETF has sold 2710 shares on 2025-12-19 at a higher price than the previous selling average. |
| CSTL - Castle Biosciences Inc | SELL | -765 @ USD 39.44 | USD -30,172 | The ETF sold 765 shares of CSTL on 2025-12-19. The shares were previously bought for an average price of USD 21.3129. The Castle Biosciences Inc shares were sold for 85.1% higher than average price of previous purchases. This sale made a profit of USD 13,867 The average price that the ETF previously sold CSTL share for is USD 24.0405 so the ETF has sold 765 shares on 2025-12-19 at a higher price than the previous selling average. |
| PHARM.AS - Pharming Group NV | SELL | -18,400 @ EUR 1.64174 | EUR -30,208 | The ETF sold 18400 shares of PHARM.AS on 2025-12-19. The shares were previously bought for an average price of EUR 0.896789. The Pharming Group NV shares were sold for 83.1% higher than average price of previous purchases. This sale made a profit of EUR 13,707 The average price that the ETF previously sold PHARM.AS share for is EUR 0.939639 so the ETF has sold 18400 shares on 2025-12-19 at a higher price than the previous selling average. |
| BLFS - BioLife Solutions Inc | SELL | -1,240 @ USD 25.07 | USD -31,087 | The ETF sold 1240 shares of BLFS on 2025-12-19. The shares were previously bought for an average price of USD 25.7305. The BioLife Solutions Inc shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 819 The average price that the ETF previously sold BLFS share for is USD 24.5417 so the ETF has sold 1240 shares on 2025-12-19 at a higher price than the previous selling average. |
| RLAY - Relay Therapeutics Inc | SELL | -3,725 @ USD 8.4 | USD -31,290 | The ETF sold 3725 shares of RLAY on 2025-12-19. The shares were previously bought for an average price of USD 5.08308. The Relay Therapeutics Inc shares were sold for 65.3% higher than average price of previous purchases. This sale made a profit of USD 12,356 The average price that the ETF previously sold RLAY share for is USD 3.97967 so the ETF has sold 3725 shares on 2025-12-19 at a higher price than the previous selling average. |
| PHM.MC - Pharma Mar SA | SELL | -355 @ EUR 89.4058 | EUR -31,739 | The ETF sold 355 shares of PHM.MC on 2025-12-19. The shares were previously bought for an average price of EUR 87.1976. The Pharma Mar SA shares were sold for 2.5% higher than average price of previous purchases. This sale made a profit of EUR 784 The average price that the ETF previously sold PHM.MC share for is EUR 85.3271 so the ETF has sold 355 shares on 2025-12-19 at a higher price than the previous selling average. |
| GLPG.AS - Galapagos NV | SELL | -995 @ EUR 32.2728 | EUR -32,111 | The ETF sold 995 shares of GLPG.AS on 2025-12-19. The shares were previously bought for an average price of EUR 29.0814. The Galapagos NV shares were sold for 11.0% higher than average price of previous purchases. This sale made a profit of EUR 3,175 The average price that the ETF previously sold GLPG.AS share for is EUR 26.8598 so the ETF has sold 995 shares on 2025-12-19 at a higher price than the previous selling average. |
| DVAX - Dynavax Technologies Corporation | SELL | -3,120 @ USD 10.86 | USD -33,883 | The ETF sold 3120 shares of DVAX on 2025-12-19. The shares were previously bought for an average price of USD 12.6313. The Dynavax Technologies Corporation shares were sold for -14.0% lower than average price of previous purchases. This resulted in an overall loss of USD 5,526 The average price that the ETF previously sold DVAX share for is USD 11.2084 which is higher than the selling price of USD 10.86 on 2025-12-19. |
| NVCR - Novocure Ltd | SELL | -2,775 @ USD 12.84 | USD -35,631 | The ETF sold 2775 shares of NVCR on 2025-12-19. The shares were previously bought for an average price of USD 16.4121. The Novocure Ltd shares were sold for -21.8% lower than average price of previous purchases. This resulted in an overall loss of USD 9,913 The average price that the ETF previously sold NVCR share for is USD 17.5463 which is higher than the selling price of USD 12.84 on 2025-12-19. |
| 2162.HK - KEYMED BIOSCIENCES INC | SELL | -5,000 @ HKD 7.13138 | HKD -35,657 | The ETF sold 5000 shares of 2162.HK on 2025-12-19. The shares were previously bought for an average price of HKD 5.35965. The KEYMED BIOSCIENCES INC shares were sold for 33.1% higher than average price of previous purchases. This sale made a profit of HKD 8,859 The average price that the ETF previously sold 2162.HK share for is HKD 5.50559 so the ETF has sold 5000 shares on 2025-12-19 at a higher price than the previous selling average. |
| ZYME - Zymeworks Inc. Common Stock | SELL | -1,345 @ USD 27.23 | USD -36,624 | The ETF sold 1345 shares of ZYME on 2025-12-19. The shares were previously bought for an average price of USD 17.6935. The Zymeworks Inc. Common Stock shares were sold for 53.9% higher than average price of previous purchases. This sale made a profit of USD 12,827 The average price that the ETF previously sold ZYME share for is USD 13.0302 so the ETF has sold 1345 shares on 2025-12-19 at a higher price than the previous selling average. |
| BIOA-B.ST - | SELL | -1,080 @ SEK 34.2075 | SEK -36,944 | The ETF sold 1080 shares of BIOA-B.ST on 2025-12-19. The shares were previously bought for an average price of SEK 29.997. The shares were sold for 14.0% higher than average price of previous purchases. This sale made a profit of SEK 4,547 The average price that the ETF previously sold BIOA-B.ST share for is SEK 20.7519 so the ETF has sold 1080 shares on 2025-12-19 at a higher price than the previous selling average. |
| AXGN - Axogen Inc | SELL | -1,160 @ USD 31.98 | USD -37,097 | The ETF sold 1160 shares of AXGN on 2025-12-19. The shares were previously bought for an average price of USD 18.047. The Axogen Inc shares were sold for 77.2% higher than average price of previous purchases. This sale made a profit of USD 16,162 The average price that the ETF previously sold AXGN share for is USD 15.681 so the ETF has sold 1160 shares on 2025-12-19 at a higher price than the previous selling average. |
| 4887.T - Sawai Group Holdings Co., Ltd. | SELL | -2,500 @ JPY 14.9103 | JPY -37,276 | The ETF sold 2500 shares of 4887.T on 2025-12-19. The shares were previously bought for an average price of JPY 13.195. The Sawai Group Holdings Co., Ltd. shares were sold for 13.0% higher than average price of previous purchases. This sale made a profit of JPY 4,288 The average price that the ETF previously sold 4887.T share for is JPY 12.8608 so the ETF has sold 2500 shares on 2025-12-19 at a higher price than the previous selling average. |
| TNDM - Tandem Diabetes Care Inc | SELL | -1,810 @ USD 22.07 | USD -39,947 | The ETF sold 1810 shares of TNDM on 2025-12-19. The shares were previously bought for an average price of USD 21.1386. The Tandem Diabetes Care Inc shares were sold for 4.4% higher than average price of previous purchases. This sale made a profit of USD 1,686 The average price that the ETF previously sold TNDM share for is USD 23.1551 which is higher than the selling price of USD 22.07 on 2025-12-19. |
| 13.HK - HUTCHMED (CHINA) LTD | SELL | -15,000 @ HKD 2.67266 | HKD -40,090 | The ETF sold 15000 shares of 13.HK on 2025-12-19. The shares were previously bought for an average price of HKD 3.01399. The HUTCHMED (CHINA) LTD shares were sold for -11.3% lower than average price of previous purchases. This resulted in an overall loss of HKD 5,120 The average price that the ETF previously sold 13.HK share for is HKD 3.07793 which is higher than the selling price of HKD 2.67266 on 2025-12-19. |
| NEOG - Neogen Corporation | SELL | -5,660 @ USD 7.2 | USD -40,752 | The ETF sold 5660 shares of NEOG on 2025-12-19. The shares were previously bought for an average price of USD 9.99438. The Neogen Corporation shares were sold for -28.0% lower than average price of previous purchases. This resulted in an overall loss of USD 15,816 The average price that the ETF previously sold NEOG share for is USD 9.05028 which is higher than the selling price of USD 7.2 on 2025-12-19. |
| BCRX - BioCryst Pharmaceuticals Inc | SELL | -5,660 @ USD 7.41 | USD -41,941 | The ETF sold 5660 shares of BCRX on 2025-12-19. The shares were previously bought for an average price of USD 7.74854. The BioCryst Pharmaceuticals Inc shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,916 The average price that the ETF previously sold BCRX share for is USD 7.91159 which is higher than the selling price of USD 7.41 on 2025-12-19. |
| RCUS - Arcus Biosciences Inc | SELL | -1,930 @ USD 21.98 | USD -42,421 | The ETF sold 1930 shares of RCUS on 2025-12-19. The shares were previously bought for an average price of USD 9.14068. The Arcus Biosciences Inc shares were sold for 140.5% higher than average price of previous purchases. This sale made a profit of USD 24,780 The average price that the ETF previously sold RCUS share for is USD 12.3725 so the ETF has sold 1930 shares on 2025-12-19 at a higher price than the previous selling average. |
| FTRE - Fortrea Holdings Inc. | SELL | -2,435 @ USD 17.74 | USD -43,197 | The ETF sold 2435 shares of FTRE on 2025-12-19. The shares were previously bought for an average price of USD 10.5322. The Fortrea Holdings Inc. shares were sold for 68.4% higher than average price of previous purchases. This sale made a profit of USD 17,551 The average price that the ETF previously sold FTRE share for is USD 10.9474 so the ETF has sold 2435 shares on 2025-12-19 at a higher price than the previous selling average. |
| HRMY - Harmony Biosciences Holdings | SELL | -1,155 @ USD 37.81 | USD -43,671 | The ETF sold 1155 shares of HRMY on 2025-12-19. The shares were previously bought for an average price of USD 32.6637. The Harmony Biosciences Holdings shares were sold for 15.8% higher than average price of previous purchases. This sale made a profit of USD 5,944 The average price that the ETF previously sold HRMY share for is USD 32.6249 so the ETF has sold 1155 shares on 2025-12-19 at a higher price than the previous selling average. |
| RXRX - Recursion Pharmaceuticals Inc | SELL | -10,360 @ USD 4.26 | USD -44,134 | The ETF sold 10360 shares of RXRX on 2025-12-19. The shares were previously bought for an average price of USD 5.14428. The Recursion Pharmaceuticals Inc shares were sold for -17.2% lower than average price of previous purchases. This resulted in an overall loss of USD 9,161 The average price that the ETF previously sold RXRX share for is USD 5.53894 which is higher than the selling price of USD 4.26 on 2025-12-19. |
| NEU.AX - | SELL | -3,430 @ AUD 12.9461 | AUD -44,405 | The ETF sold 3430 shares of NEU.AX on 2025-12-19. The shares were previously bought for an average price of AUD 8.87049. The shares were sold for 45.9% higher than average price of previous purchases. This sale made a profit of AUD 13,979 The average price that the ETF previously sold NEU.AX share for is AUD 8.44163 so the ETF has sold 3430 shares on 2025-12-19 at a higher price than the previous selling average. |
| STOK - Stoke Therapeutics Inc | SELL | -1,415 @ USD 31.96 | USD -45,223 | The ETF sold 1415 shares of STOK on 2025-12-19. The shares were previously bought for an average price of USD 12.0607. The Stoke Therapeutics Inc shares were sold for 165.0% higher than average price of previous purchases. This sale made a profit of USD 28,158 The average price that the ETF previously sold STOK share for is USD 13.5099 so the ETF has sold 1415 shares on 2025-12-19 at a higher price than the previous selling average. |
| 6951.T - JEOL Ltd. | SELL | -1,500 @ JPY 30.5636 | JPY -45,845 | The ETF sold 1500 shares of 6951.T on 2025-12-19. The shares were previously bought for an average price of JPY 33.0489. The JEOL Ltd. shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of JPY 3,728 The average price that the ETF previously sold 6951.T share for is JPY 32.3999 which is higher than the selling price of JPY 30.5636 on 2025-12-19. |
| TXG - 10X Genomics Inc | SELL | -2,880 @ USD 16.05 | USD -46,224 | The ETF sold 2880 shares of TXG on 2025-12-19. The shares were previously bought for an average price of USD 12.5355. The 10X Genomics Inc shares were sold for 28.0% higher than average price of previous purchases. This sale made a profit of USD 10,122 The average price that the ETF previously sold TXG share for is USD 11.4426 so the ETF has sold 2880 shares on 2025-12-19 at a higher price than the previous selling average. |
| TXG - Terex Corporation | SELL | -2,880 @ USD 16.05 | USD -46,224 | The ETF sold 2880 shares of TXG on 2025-12-19. The shares were previously bought for an average price of USD 12.5355. The Terex Corporation shares were sold for 28.0% higher than average price of previous purchases. This sale made a profit of USD 10,122 The average price that the ETF previously sold TXG share for is USD 11.4426 so the ETF has sold 2880 shares on 2025-12-19 at a higher price than the previous selling average. |
| 3933.HK - THE UNITED LABORATORIES INTERNATIO | SELL | -30,000 @ HKD 1.59974 | HKD -47,992 | The ETF sold 30000 shares of 3933.HK on 2025-12-19. The shares were previously bought for an average price of HKD 1.67688. The THE UNITED LABORATORIES INTERNATIO shares were sold for -4.6% lower than average price of previous purchases. This resulted in an overall loss of HKD 2,314 The average price that the ETF previously sold 3933.HK share for is HKD 1.60176 which is higher than the selling price of HKD 1.59974 on 2025-12-19. |
| HLUN-B.CO - | SELL | -7,100 @ DKK 6.77137 | DKK -48,077 | The ETF sold 7100 shares of HLUN-B.CO on 2025-12-19. The shares were previously bought for an average price of DKK 6.0023. The shares were sold for 12.8% higher than average price of previous purchases. This sale made a profit of DKK 5,460 The average price that the ETF previously sold HLUN-B.CO share for is DKK 5.27435 so the ETF has sold 7100 shares on 2025-12-19 at a higher price than the previous selling average. |
| TWST - Twist Bioscience Corp | SELL | -1,485 @ USD 32.51 | USD -48,277 | The ETF sold 1485 shares of TWST on 2025-12-19. The shares were previously bought for an average price of USD 36.2456. The Twist Bioscience Corp shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of USD 5,547 The average price that the ETF previously sold TWST share for is USD 38.1744 which is higher than the selling price of USD 32.51 on 2025-12-19. |
| CHEMM.CO - | SELL | -460 @ DKK 106.9 | DKK -49,174 | The ETF sold 460 shares of CHEMM.CO on 2025-12-19. The shares were previously bought for an average price of DKK 78.2284. The shares were sold for 36.7% higher than average price of previous purchases. This sale made a profit of DKK 13,189 The average price that the ETF previously sold CHEMM.CO share for is DKK 75.6566 so the ETF has sold 460 shares on 2025-12-19 at a higher price than the previous selling average. |
| KNSA - Kiniksa Pharmaceuticals Ltd | SELL | -1,140 @ USD 43.19 | USD -49,237 | The ETF sold 1140 shares of KNSA on 2025-12-19. The shares were previously bought for an average price of USD 40.3374. The Kiniksa Pharmaceuticals Ltd shares were sold for 7.1% higher than average price of previous purchases. This sale made a profit of USD 3,252 The average price that the ETF previously sold KNSA share for is USD 36.3406 so the ETF has sold 1140 shares on 2025-12-19 at a higher price than the previous selling average. |
| 9995.HK - REMEGEN LTD H | SELL | -5,000 @ HKD 10.061 | HKD -50,305 | The ETF sold 5000 shares of 9995.HK on 2025-12-19. The shares were previously bought for an average price of HKD 9.70899. The REMEGEN LTD H shares were sold for 3.6% higher than average price of previous purchases. This sale made a profit of HKD 1,760 The average price that the ETF previously sold 9995.HK share for is HKD 4.30885 so the ETF has sold 5000 shares on 2025-12-19 at a higher price than the previous selling average. |
| QDEL - Quidel Corporation | SELL | -1,750 @ USD 28.95 | USD -50,663 | The ETF sold 1750 shares of QDEL on 2025-12-19. The shares were previously bought for an average price of USD 29.52. The Quidel Corporation shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 998 The average price that the ETF previously sold QDEL share for is USD 32.5515 which is higher than the selling price of USD 28.95 on 2025-12-19. |
| DIA.MI - DiaSorin SpA | SELL | -680 @ EUR 75.3187 | EUR -51,217 | The ETF sold 680 shares of DIA.MI on 2025-12-19. The shares were previously bought for an average price of EUR 54.1257. The DiaSorin SpA shares were sold for 39.2% higher than average price of previous purchases. This sale made a profit of EUR 14,411 The average price that the ETF previously sold DIA.MI share for is EUR 107.4 which is higher than the selling price of EUR 75.3187 on 2025-12-19. |
| ATRC - AtriCure Inc | SELL | -1,295 @ USD 40.95 | USD -53,030 | The ETF sold 1295 shares of ATRC on 2025-12-19. The shares were previously bought for an average price of USD 33.402. The AtriCure Inc shares were sold for 22.6% higher than average price of previous purchases. This sale made a profit of USD 9,775 The average price that the ETF previously sold ATRC share for is USD 33.8407 so the ETF has sold 1295 shares on 2025-12-19 at a higher price than the previous selling average. |
| CRVL - CorVel Corp | SELL | -775 @ USD 68.78 | USD -53,305 | The ETF sold 775 shares of CRVL on 2025-12-19. The shares were previously bought for an average price of USD 111.522. The CorVel Corp shares were sold for -38.3% lower than average price of previous purchases. This resulted in an overall loss of USD 33,125 The average price that the ETF previously sold CRVL share for is USD 134.629 which is higher than the selling price of USD 68.78 on 2025-12-19. |
| TECN.SW - | SELL | -335 @ CHF 160.206 | CHF -53,669 | The ETF sold 335 shares of TECN.SW on 2025-12-19. The shares were previously bought for an average price of CHF 197.12. The shares were sold for -18.7% lower than average price of previous purchases. This resulted in an overall loss of CHF 12,366 The average price that the ETF previously sold TECN.SW share for is CHF 205.32 which is higher than the selling price of CHF 160.206 on 2025-12-19. |
| SRPT - Sarepta Therapeutics Inc | SELL | -2,635 @ USD 21.04 | USD -55,440 | The ETF sold 2635 shares of SRPT on 2025-12-19. The shares were previously bought for an average price of USD 45.0034. The Sarepta Therapeutics Inc shares were sold for -53.2% lower than average price of previous purchases. This resulted in an overall loss of USD 63,144 The average price that the ETF previously sold SRPT share for is USD 66.7223 which is higher than the selling price of USD 21.04 on 2025-12-19. |
| AUPH - Aurinia Pharmaceuticals Inc | SELL | -3,480 @ USD 16.18 | USD -56,306 | The ETF sold 3480 shares of AUPH on 2025-12-19. The shares were previously bought for an average price of USD 11.2153. The Aurinia Pharmaceuticals Inc shares were sold for 44.3% higher than average price of previous purchases. This sale made a profit of USD 17,277 The average price that the ETF previously sold AUPH share for is USD 8.65588 so the ETF has sold 3480 shares on 2025-12-19 at a higher price than the previous selling average. |
| BANB.SW - | SELL | -820 @ CHF 71.5587 | CHF -58,678 | The ETF sold 820 shares of BANB.SW on 2025-12-19. The shares were previously bought for an average price of CHF 65.0923. The shares were sold for 9.9% higher than average price of previous purchases. This sale made a profit of CHF 5,302 The average price that the ETF previously sold BANB.SW share for is CHF 67.402 so the ETF has sold 820 shares on 2025-12-19 at a higher price than the previous selling average. |
| EKTA-B.ST - | SELL | -9,775 @ SEK 6.08003 | SEK -59,432 | The ETF sold 9775 shares of EKTA-B.ST on 2025-12-19. The shares were previously bought for an average price of SEK 5.63298. The shares were sold for 7.9% higher than average price of previous purchases. This sale made a profit of SEK 4,370 The average price that the ETF previously sold EKTA-B.ST share for is SEK 5.13099 so the ETF has sold 9775 shares on 2025-12-19 at a higher price than the previous selling average. |
| NUVB - Nuvation Bio Inc | SELL | -6,395 @ USD 9.44 | USD -60,369 | The ETF sold 6395 shares of NUVB on 2025-12-19. The shares were previously bought for an average price of USD 6.64051. The Nuvation Bio Inc shares were sold for 42.2% higher than average price of previous purchases. This sale made a profit of USD 17,903 The average price that the ETF previously sold NUVB share for is USD 4.7298 so the ETF has sold 6395 shares on 2025-12-19 at a higher price than the previous selling average. |
| BAVA.CO - | SELL | -2,070 @ DKK 29.6561 | DKK -61,388 | The ETF sold 2070 shares of BAVA.CO on 2025-12-19. The shares were previously bought for an average price of DKK 25.4205. The shares were sold for 16.7% higher than average price of previous purchases. This sale made a profit of DKK 8,768 The average price that the ETF previously sold BAVA.CO share for is DKK 25.9295 so the ETF has sold 2070 shares on 2025-12-19 at a higher price than the previous selling average. |
| CGON - CG Oncology, Inc. Common stock | SELL | -1,625 @ USD 39.03 | USD -63,424 | The ETF sold 1625 shares of CGON on 2025-12-19. The shares were previously bought for an average price of USD 41.6925. The CG Oncology, Inc. Common stock shares were sold for -6.4% lower than average price of previous purchases. This resulted in an overall loss of USD 4,327 The average price that the ETF previously sold CGON share for is USD 35.8169 so the ETF has sold 1625 shares on 2025-12-19 at a higher price than the previous selling average. |
| 326030.KS - SK BIOPHARMACEUTICALS LTD | SELL | -735 @ KRW 87.2331 | KRW -64,116 | The ETF sold 735 shares of 326030.KS on 2025-12-19. The shares were previously bought for an average price of KRW 77.4592. The SK BIOPHARMACEUTICALS LTD shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of KRW 7,184 The average price that the ETF previously sold 326030.KS share for is KRW 73.038 so the ETF has sold 735 shares on 2025-12-19 at a higher price than the previous selling average. |
| ADPT - Adaptive Biotechnologies Corp | SELL | -3,990 @ USD 17 | USD -67,830 | The ETF sold 3990 shares of ADPT on 2025-12-19. The shares were previously bought for an average price of USD 6.89362. The Adaptive Biotechnologies Corp shares were sold for 146.6% higher than average price of previous purchases. This sale made a profit of USD 40,324 The average price that the ETF previously sold ADPT share for is USD 8.47525 so the ETF has sold 3990 shares on 2025-12-19 at a higher price than the previous selling average. |
| VRDN - Viridian Therapeutics Inc | SELL | -2,185 @ USD 31.92 | USD -69,745 | The ETF sold 2185 shares of VRDN on 2025-12-19. The shares were previously bought for an average price of USD 30.1226. The Viridian Therapeutics Inc shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 3,927 The average price that the ETF previously sold VRDN share for is USD 23.6698 so the ETF has sold 2185 shares on 2025-12-19 at a higher price than the previous selling average. |
| ACLX - Arcellx Inc | SELL | -1,100 @ USD 63.96 | USD -70,356 | The ETF sold 1100 shares of ACLX on 2025-12-19. The shares were previously bought for an average price of USD 64.8725. The Arcellx Inc shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,004 The average price that the ETF previously sold ACLX share for is USD 72.1631 which is higher than the selling price of USD 63.96 on 2025-12-19. |
| BEAM - Beam Therapeutics Inc | SELL | -2,675 @ USD 26.57 | USD -71,075 | The ETF sold 2675 shares of BEAM on 2025-12-19. The shares were previously bought for an average price of USD 18.6816. The Beam Therapeutics Inc shares were sold for 42.2% higher than average price of previous purchases. This sale made a profit of USD 21,101 The average price that the ETF previously sold BEAM share for is USD 21.1916 so the ETF has sold 2675 shares on 2025-12-19 at a higher price than the previous selling average. |
| SUPN - Supernus Pharmaceuticals Inc | SELL | -1,460 @ USD 51.48 | USD -75,161 | The ETF sold 1460 shares of SUPN on 2025-12-19. The shares were previously bought for an average price of USD 36.2354. The Supernus Pharmaceuticals Inc shares were sold for 42.1% higher than average price of previous purchases. This sale made a profit of USD 22,257 The average price that the ETF previously sold SUPN share for is USD 35.0119 so the ETF has sold 1460 shares on 2025-12-19 at a higher price than the previous selling average. |
| CPRX - Catalyst Pharmaceuticals Inc | SELL | -3,230 @ USD 23.74 | USD -76,680 | The ETF sold 3230 shares of CPRX on 2025-12-19. The shares were previously bought for an average price of USD 22.4325. The Catalyst Pharmaceuticals Inc shares were sold for 5.8% higher than average price of previous purchases. This sale made a profit of USD 4,223 The average price that the ETF previously sold CPRX share for is USD 22.4243 so the ETF has sold 3230 shares on 2025-12-19 at a higher price than the previous selling average. |
| IDYA - Ideaya Biosciences Inc | SELL | -2,315 @ USD 33.55 | USD -77,668 | The ETF sold 2315 shares of IDYA on 2025-12-19. The shares were previously bought for an average price of USD 23.8167. The Ideaya Biosciences Inc shares were sold for 40.9% higher than average price of previous purchases. This sale made a profit of USD 22,533 The average price that the ETF previously sold IDYA share for is USD 22.4366 so the ETF has sold 2315 shares on 2025-12-19 at a higher price than the previous selling average. |
| VCYT - Veracyte Inc | SELL | -1,925 @ USD 42.92 | USD -82,621 | The ETF sold 1925 shares of VCYT on 2025-12-19. The shares were previously bought for an average price of USD 34.3612. The Veracyte Inc shares were sold for 24.9% higher than average price of previous purchases. This sale made a profit of USD 16,476 The average price that the ETF previously sold VCYT share for is USD 34.1447 so the ETF has sold 1925 shares on 2025-12-19 at a higher price than the previous selling average. |
| LIVN - LivaNova PLC | SELL | -1,405 @ USD 62.82 | USD -88,262 | The ETF sold 1405 shares of LIVN on 2025-12-19. The shares were previously bought for an average price of USD 46.485. The LivaNova PLC shares were sold for 35.1% higher than average price of previous purchases. This sale made a profit of USD 22,951 The average price that the ETF previously sold LIVN share for is USD 45.4432 so the ETF has sold 1405 shares on 2025-12-19 at a higher price than the previous selling average. |
| ACAD - ACADIA Pharmaceuticals Inc | SELL | -3,260 @ USD 27.16 | USD -88,542 | The ETF sold 3260 shares of ACAD on 2025-12-19. The shares were previously bought for an average price of USD 20.1364. The ACADIA Pharmaceuticals Inc shares were sold for 34.9% higher than average price of previous purchases. This sale made a profit of USD 22,897 The average price that the ETF previously sold ACAD share for is USD 17.7171 so the ETF has sold 3260 shares on 2025-12-19 at a higher price than the previous selling average. |
| SFZN.SW - | SELL | -1,045 @ CHF 93.108 | CHF -97,298 | The ETF sold 1045 shares of SFZN.SW on 2025-12-19. The shares were previously bought for an average price of CHF 123.569. The shares were sold for -24.7% lower than average price of previous purchases. This resulted in an overall loss of CHF 31,832 The average price that the ETF previously sold SFZN.SW share for is CHF 275.995 which is higher than the selling price of CHF 93.108 on 2025-12-19. |
| LGND - Ligand Pharmaceuticals Incorporated | SELL | -505 @ USD 200.33 | USD -101,167 | The ETF sold 505 shares of LGND on 2025-12-19. The shares were previously bought for an average price of USD 126.392. The Ligand Pharmaceuticals Incorporated shares were sold for 58.5% higher than average price of previous purchases. This sale made a profit of USD 37,339 The average price that the ETF previously sold LGND share for is USD 120.859 so the ETF has sold 505 shares on 2025-12-19 at a higher price than the previous selling average. |
| SECT-B.ST - | SELL | -3,845 @ SEK 27.2713 | SEK -104,858 | The ETF sold 3845 shares of SECT-B.ST on 2025-12-19. The shares were previously bought for an average price of SEK 28.0136. The shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of SEK 2,854 The average price that the ETF previously sold SECT-B.ST share for is SEK 28.7912 which is higher than the selling price of SEK 27.2713 on 2025-12-19. |
| TGTX - TG Therapeutics Inc | SELL | -3,755 @ USD 30.98 | USD -116,330 | The ETF sold 3755 shares of TGTX on 2025-12-19. The shares were previously bought for an average price of USD 33.8235. The TG Therapeutics Inc shares were sold for -8.4% lower than average price of previous purchases. This resulted in an overall loss of USD 10,677 The average price that the ETF previously sold TGTX share for is USD 34.1826 which is higher than the selling price of USD 30.98 on 2025-12-19. |
| 298380.KQ - ABL Bio Inc. | SELL | -910 @ KRW 128.853 | KRW -117,256 | The ETF sold 910 shares of 298380.KQ on 2025-12-19. The shares were previously bought for an average price of KRW 40.1877. The ABL Bio Inc. shares were sold for 220.6% higher than average price of previous purchases. This sale made a profit of KRW 80,685 The average price that the ETF previously sold 298380.KQ share for is KRW 40.4325 so the ETF has sold 910 shares on 2025-12-19 at a higher price than the previous selling average. |
| LNTH - Lantheus Holdings Inc | SELL | -1,815 @ USD 65.92 | USD -119,645 | The ETF sold 1815 shares of LNTH on 2025-12-19. The shares were previously bought for an average price of USD 76.9588. The Lantheus Holdings Inc shares were sold for -14.3% lower than average price of previous purchases. This resulted in an overall loss of USD 20,035 The average price that the ETF previously sold LNTH share for is USD 86.7285 which is higher than the selling price of USD 65.92 on 2025-12-19. |
| ALKS - Alkermes Plc | SELL | -4,310 @ USD 28.45 | USD -122,620 | The ETF sold 4310 shares of ALKS on 2025-12-19. The shares were previously bought for an average price of USD 30.7179. The Alkermes Plc shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 9,775 The average price that the ETF previously sold ALKS share for is USD 29.443 which is higher than the selling price of USD 28.45 on 2025-12-19. |
| 7747.T - Asahi Intecc Co., Ltd. | SELL | -6,500 @ JPY 19.1141 | JPY -124,242 | The ETF sold 6500 shares of 7747.T on 2025-12-19. The shares were previously bought for an average price of JPY 16.8906. The Asahi Intecc Co., Ltd. shares were sold for 13.2% higher than average price of previous purchases. This sale made a profit of JPY 14,453 The average price that the ETF previously sold 7747.T share for is JPY 16.0322 so the ETF has sold 6500 shares on 2025-12-19 at a higher price than the previous selling average. |
| MMS - LYXETFETUSITETFP | SELL | -1,470 @ USD 88.09 | USD -129,492 | The ETF sold 1470 shares of MMS on 2025-12-19. The shares were previously bought for an average price of USD 75.2803. The LYXETFETUSITETFP shares were sold for 17.0% higher than average price of previous purchases. This sale made a profit of USD 18,830 The average price that the ETF previously sold MMS share for is USD 72.3848 so the ETF has sold 1470 shares on 2025-12-19 at a higher price than the previous selling average. |
| IPN.PA - Ipsen SA | SELL | -945 @ EUR 140.871 | EUR -133,123 | The ETF sold 945 shares of IPN.PA on 2025-12-19. The shares were previously bought for an average price of EUR 120.641. The Ipsen SA shares were sold for 16.8% higher than average price of previous purchases. This sale made a profit of EUR 19,117 The average price that the ETF previously sold IPN.PA share for is EUR 117.845 so the ETF has sold 945 shares on 2025-12-19 at a higher price than the previous selling average. |
| 6869.T - Sysmex Corporation | SELL | -13,500 @ JPY 9.91586 | JPY -133,864 | The ETF sold 13500 shares of 6869.T on 2025-12-19. The shares were previously bought for an average price of JPY 14.9756. The Sysmex Corporation shares were sold for -33.8% lower than average price of previous purchases. This resulted in an overall loss of JPY 68,306 The average price that the ETF previously sold 6869.T share for is JPY 17.6931 which is higher than the selling price of JPY 9.91586 on 2025-12-19. |
| PRAX - Praxis Precision Medicines Inc | SELL | -535 @ USD 272.92 | USD -146,012 | The ETF sold 535 shares of PRAX on 2025-12-19. The shares were previously bought for an average price of USD 167.342. The Praxis Precision Medicines Inc shares were sold for 63.1% higher than average price of previous purchases. This sale made a profit of USD 56,484 The average price that the ETF previously sold PRAX share for is USD 155.098 so the ETF has sold 535 shares on 2025-12-19 at a higher price than the previous selling average. |
| AXSM - Axsome Therapeutics Inc | SELL | -1,000 @ USD 152.65 | USD -152,650 | The ETF sold 1000 shares of AXSM on 2025-12-19. The shares were previously bought for an average price of USD 116.831. The Axsome Therapeutics Inc shares were sold for 30.7% higher than average price of previous purchases. This sale made a profit of USD 35,819 The average price that the ETF previously sold AXSM share for is USD 107.338 so the ETF has sold 1000 shares on 2025-12-19 at a higher price than the previous selling average. |
| PTCT - PTC Therapeutics Inc | SELL | -2,060 @ USD 78.57 | USD -161,854 | The ETF sold 2060 shares of PTCT on 2025-12-19. The shares were previously bought for an average price of USD 56.4444. The PTC Therapeutics Inc shares were sold for 39.2% higher than average price of previous purchases. This sale made a profit of USD 45,579 The average price that the ETF previously sold PTCT share for is USD 49.2415 so the ETF has sold 2060 shares on 2025-12-19 at a higher price than the previous selling average. |
| BIM.PA - BioMerieux | SELL | -1,270 @ EUR 127.522 | EUR -161,953 | The ETF sold 1270 shares of BIM.PA on 2025-12-19. The shares were previously bought for an average price of EUR 121.406. The BioMerieux shares were sold for 5.0% higher than average price of previous purchases. This sale made a profit of EUR 7,767 The average price that the ETF previously sold BIM.PA share for is EUR 123.127 so the ETF has sold 1270 shares on 2025-12-19 at a higher price than the previous selling average. |
| BIO - Bio-Rad Laboratories Inc | SELL | -555 @ USD 301.53 | USD -167,349 | The ETF sold 555 shares of BIO on 2025-12-19. The shares were previously bought for an average price of USD 290.296. The Bio-Rad Laboratories Inc shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 6,235 The average price that the ETF previously sold BIO share for is USD 269.237 so the ETF has sold 555 shares on 2025-12-19 at a higher price than the previous selling average. |
| BIO - Biotest Aktiengesellschaft | SELL | -555 @ USD 301.53 | USD -167,349 | The ETF sold 555 shares of BIO on 2025-12-19. The shares were previously bought for an average price of USD 290.296. The Biotest Aktiengesellschaft shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 6,235 The average price that the ETF previously sold BIO share for is USD 269.237 so the ETF has sold 555 shares on 2025-12-19 at a higher price than the previous selling average. |
| RYTM - Rhythm Pharmaceuticals Inc | SELL | -1,510 @ USD 112.14 | USD -169,331 | The ETF sold 1510 shares of RYTM on 2025-12-19. The shares were previously bought for an average price of USD 67.8137. The Rhythm Pharmaceuticals Inc shares were sold for 65.4% higher than average price of previous purchases. This sale made a profit of USD 66,933 The average price that the ETF previously sold RYTM share for is USD 64.7963 so the ETF has sold 1510 shares on 2025-12-19 at a higher price than the previous selling average. |
| SRT3.DE - Sartorius AG | SELL | -660 @ EUR 281.157 | EUR -185,564 | The ETF sold 660 shares of SRT3.DE on 2025-12-19. The shares were previously bought for an average price of EUR 247.576. The Sartorius AG shares were sold for 13.6% higher than average price of previous purchases. This sale made a profit of EUR 22,163 The average price that the ETF previously sold SRT3.DE share for is EUR 241.362 so the ETF has sold 660 shares on 2025-12-19 at a higher price than the previous selling average. |
| 7701.T - Shimadzu Corporation | SELL | -7,500 @ JPY 26.8551 | JPY -201,413 | The ETF sold 7500 shares of 7701.T on 2025-12-19. The shares were previously bought for an average price of JPY 26.4723. The Shimadzu Corporation shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of JPY 2,871 The average price that the ETF previously sold 7701.T share for is JPY 26.1169 so the ETF has sold 7500 shares on 2025-12-19 at a higher price than the previous selling average. |
| PME.AX - | SELL | -1,465 @ AUD 143.649 | AUD -210,446 | The ETF sold 1465 shares of PME.AX on 2025-12-19. The shares were previously bought for an average price of AUD 165.183. The shares were sold for -13.0% lower than average price of previous purchases. This resulted in an overall loss of AUD 31,547 The average price that the ETF previously sold PME.AX share for is AUD 150.114 which is higher than the selling price of AUD 143.649 on 2025-12-19. |
| 4523.T - Eisai Co., Ltd. | SELL | -7,500 @ JPY 28.6268 | JPY -214,701 | The ETF sold 7500 shares of 4523.T on 2025-12-19. The shares were previously bought for an average price of JPY 28.5269. The Eisai Co., Ltd. shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of JPY 749 The average price that the ETF previously sold 4523.T share for is JPY 28.5834 so the ETF has sold 7500 shares on 2025-12-19 at a higher price than the previous selling average. |
| HALO - Halozyme Therapeutics Inc | SELL | -3,220 @ USD 67.35 | USD -216,867 | The ETF sold 3220 shares of HALO on 2025-12-19. The shares were previously bought for an average price of USD 60.3305. The Halozyme Therapeutics Inc shares were sold for 11.6% higher than average price of previous purchases. This sale made a profit of USD 22,603 The average price that the ETF previously sold HALO share for is USD 54.9842 so the ETF has sold 3220 shares on 2025-12-19 at a higher price than the previous selling average. |
| RGEN - Repligen Corporation | SELL | -1,370 @ USD 162.38 | USD -222,461 | The ETF sold 1370 shares of RGEN on 2025-12-19. The shares were previously bought for an average price of USD 145.299. The Repligen Corporation shares were sold for 11.8% higher than average price of previous purchases. This sale made a profit of USD 23,401 The average price that the ETF previously sold RGEN share for is USD 135.629 so the ETF has sold 1370 shares on 2025-12-19 at a higher price than the previous selling average. |
| TECH - Bio-Techne Corp | SELL | -4,095 @ USD 58.27 | USD -238,616 | The ETF sold 4095 shares of TECH on 2025-12-19. The shares were previously bought for an average price of USD 59.3169. The Bio-Techne Corp shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 4,287 The average price that the ETF previously sold TECH share for is USD 58.9444 which is higher than the selling price of USD 58.27 on 2025-12-19. |
| DXCM - DexCom Inc | SELL | -3,785 @ USD 66.06 | USD -250,037 | The ETF sold 3785 shares of DXCM on 2025-12-19. The shares were previously bought for an average price of USD 78.8148. The DexCom Inc shares were sold for -16.2% lower than average price of previous purchases. This resulted in an overall loss of USD 48,277 The average price that the ETF previously sold DXCM share for is USD 73.9002 which is higher than the selling price of USD 66.06 on 2025-12-19. |
| CRL - Creightons Plc | SELL | -1,280 @ USD 197.06 | USD -252,237 | The ETF sold 1280 shares of CRL on 2025-12-19. The shares were previously bought for an average price of USD 165.907. The Creightons Plc shares were sold for 18.8% higher than average price of previous purchases. This sale made a profit of USD 39,876 The average price that the ETF previously sold CRL share for is USD 155.379 so the ETF has sold 1280 shares on 2025-12-19 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -3,075 @ USD 96.24 | USD -295,938 | The ETF sold 3075 shares of RVTY on 2025-12-19. The shares were previously bought for an average price of USD 100.003. The Revvity Inc. shares were sold for -3.8% lower than average price of previous purchases. This resulted in an overall loss of USD 11,571 The average price that the ETF previously sold RVTY share for is USD 96.658 which is higher than the selling price of USD 96.24 on 2025-12-19. |
| ABT - Abbott Laboratories | SELL | -2,390 @ USD 125.45 | USD -299,826 | The ETF sold 2390 shares of ABT on 2025-12-19. The shares were previously bought for an average price of USD 124.674. The Abbott Laboratories shares were sold for 0.6% higher than average price of previous purchases. This sale made a profit of USD 1,855 The average price that the ETF previously sold ABT share for is USD 128.945 which is higher than the selling price of USD 125.45 on 2025-12-19. |
| LONN.SW - | SELL | -455 @ CHF 669.473 | CHF -304,610 | The ETF sold 455 shares of LONN.SW on 2025-12-19. The shares were previously bought for an average price of CHF 640.611. The shares were sold for 4.5% higher than average price of previous purchases. This sale made a profit of CHF 13,132 The average price that the ETF previously sold LONN.SW share for is CHF 663.412 so the ETF has sold 455 shares on 2025-12-19 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -3,230 @ USD 95.61 | USD -308,820 | The ETF sold 3230 shares of BSX on 2025-12-19. The shares were previously bought for an average price of USD 97.6281. The Boston Scientific Corporation shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 6,518 The average price that the ETF previously sold BSX share for is USD 98.6682 which is higher than the selling price of USD 95.61 on 2025-12-19. |
| BSX - MULSTRXSSXIMETFP | SELL | -3,230 @ USD 95.61 | USD -308,820 | The ETF sold 3230 shares of BSX on 2025-12-19. The shares were previously bought for an average price of USD 97.6281. The MULSTRXSSXIMETFP shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 6,518 The average price that the ETF previously sold BSX share for is USD 98.6682 which is higher than the selling price of USD 95.61 on 2025-12-19. |
| PODD - Insulet Corporation | SELL | -1,075 @ USD 289.62 | USD -311,342 | The ETF sold 1075 shares of PODD on 2025-12-19. The shares were previously bought for an average price of USD 282.956. The Insulet Corporation shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 7,164 The average price that the ETF previously sold PODD share for is USD 292.775 which is higher than the selling price of USD 289.62 on 2025-12-19. |
| EXEL - Exelixis Inc | SELL | -7,120 @ USD 44.3 | USD -315,416 | The ETF sold 7120 shares of EXEL on 2025-12-19. The shares were previously bought for an average price of USD 38.1215. The Exelixis Inc shares were sold for 16.2% higher than average price of previous purchases. This sale made a profit of USD 43,991 The average price that the ETF previously sold EXEL share for is USD 38.8127 so the ETF has sold 7120 shares on 2025-12-19 at a higher price than the previous selling average. |
| 207940.KS - SAMSUNG BIOLOGICS LTD | SELL | -275 @ KRW 1172.81 | KRW -322,523 | The ETF sold 275 shares of 207940.KS on 2025-12-19. The shares were previously bought for an average price of KRW 760.081. The SAMSUNG BIOLOGICS LTD shares were sold for 54.3% higher than average price of previous purchases. This sale made a profit of KRW 113,500 The average price that the ETF previously sold 207940.KS share for is KRW 962.167 so the ETF has sold 275 shares on 2025-12-19 at a higher price than the previous selling average. |
| GH - Guardant Health Inc | SELL | -3,235 @ USD 99.74 | USD -322,659 | The ETF sold 3235 shares of GH on 2025-12-19. The shares were previously bought for an average price of USD 54.9629. The Guardant Health Inc shares were sold for 81.5% higher than average price of previous purchases. This sale made a profit of USD 144,854 The average price that the ETF previously sold GH share for is USD 45.1687 so the ETF has sold 3235 shares on 2025-12-19 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -13,215 @ USD 25.19 | USD -332,886 | The ETF sold 13215 shares of PFE on 2025-12-19. The shares were previously bought for an average price of USD 24.3485. The Pfizer Inc shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of USD 11,120 The average price that the ETF previously sold PFE share for is USD 24.3838 so the ETF has sold 13215 shares on 2025-12-19 at a higher price than the previous selling average. |
| 068270.KS - CELLTRION INC | SELL | -2,700 @ KRW 124.86 | KRW -337,122 | The ETF sold 2700 shares of 068270.KS on 2025-12-19. The shares were previously bought for an average price of KRW 121.694. The CELLTRION INC shares were sold for 2.6% higher than average price of previous purchases. This sale made a profit of KRW 8,548 The average price that the ETF previously sold 068270.KS share for is KRW 119.984 so the ETF has sold 2700 shares on 2025-12-19 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -10,095 @ USD 33.8 | USD -341,211 | The ETF sold 10095 shares of MRNA on 2025-12-19. The shares were previously bought for an average price of USD 25.9653. The Moderna Inc shares were sold for 30.2% higher than average price of previous purchases. This sale made a profit of USD 79,091 The average price that the ETF previously sold MRNA share for is USD 30.267 so the ETF has sold 10095 shares on 2025-12-19 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -605 @ USD 572.47 | USD -346,344 | The ETF sold 605 shares of ISRG on 2025-12-19. The shares were previously bought for an average price of USD 536.021. The Intuitive Surgical Inc shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 22,052 The average price that the ETF previously sold ISRG share for is USD 518.627 so the ETF has sold 605 shares on 2025-12-19 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -6,425 @ USD 54.19 | USD -348,171 | The ETF sold 6425 shares of BMY on 2025-12-19. The shares were previously bought for an average price of USD 53.3317. The Bloomsbury Publishing Plc shares were sold for 1.6% higher than average price of previous purchases. This sale made a profit of USD 5,515 The average price that the ETF previously sold BMY share for is USD 50.692 so the ETF has sold 6425 shares on 2025-12-19 at a higher price than the previous selling average. |
| MEDP - Medpace Holdings Inc | SELL | -625 @ USD 568.36 | USD -355,225 | The ETF sold 625 shares of MEDP on 2025-12-19. The shares were previously bought for an average price of USD 382.527. The Medpace Holdings Inc shares were sold for 48.6% higher than average price of previous purchases. This sale made a profit of USD 116,146 The average price that the ETF previously sold MEDP share for is USD 345.678 so the ETF has sold 625 shares on 2025-12-19 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -1,585 @ USD 224.84 | USD -356,371 | The ETF sold 1585 shares of DHR on 2025-12-19. The shares were previously bought for an average price of USD 199.979. The Danaher Corporation shares were sold for 12.4% higher than average price of previous purchases. This sale made a profit of USD 39,405 The average price that the ETF previously sold DHR share for is USD 210.476 so the ETF has sold 1585 shares on 2025-12-19 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -1,585 @ USD 224.84 | USD -356,371 | The ETF sold 1585 shares of DHR on 2025-12-19. The shares were previously bought for an average price of USD 199.979. The Danaher Corporation shares were sold for 12.4% higher than average price of previous purchases. This sale made a profit of USD 39,405 The average price that the ETF previously sold DHR share for is USD 210.476 so the ETF has sold 1585 shares on 2025-12-19 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -1,095 @ USD 327.38 | USD -358,481 | The ETF sold 1095 shares of AMGN on 2025-12-19. The shares were previously bought for an average price of USD 296.507. The Amgen Inc shares were sold for 10.4% higher than average price of previous purchases. This sale made a profit of USD 33,806 The average price that the ETF previously sold AMGN share for is USD 292.208 so the ETF has sold 1095 shares on 2025-12-19 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -3,650 @ USD 98.63 | USD -360,000 | The ETF sold 3650 shares of MDT on 2025-12-19. The shares were previously bought for an average price of USD 90.2193. The Medtronic PLC shares were sold for 9.3% higher than average price of previous purchases. This sale made a profit of USD 30,699 The average price that the ETF previously sold MDT share for is USD 87.0797 so the ETF has sold 3650 shares on 2025-12-19 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -2,915 @ USD 124.29 | USD -362,305 | The ETF sold 2915 shares of GILD on 2025-12-19. The shares were previously bought for an average price of USD 107.342. The Guild Esports Plc shares were sold for 15.8% higher than average price of previous purchases. This sale made a profit of USD 49,403 The average price that the ETF previously sold GILD share for is USD 106.222 so the ETF has sold 2915 shares on 2025-12-19 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -4,235 @ USD 85.66 | USD -362,770 | The ETF sold 4235 shares of EW on 2025-12-19. The shares were previously bought for an average price of USD 74.591. The Edwards Lifesciences Corp shares were sold for 14.8% higher than average price of previous purchases. This sale made a profit of USD 46,877 The average price that the ETF previously sold EW share for is USD 73.2539 so the ETF has sold 4235 shares on 2025-12-19 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -2,660 @ USD 137.24 | USD -365,058 | The ETF sold 2660 shares of A on 2025-12-19. The shares were previously bought for an average price of USD 122.269. The Agilent Technologies Inc shares were sold for 12.2% higher than average price of previous purchases. This sale made a profit of USD 39,823 The average price that the ETF previously sold A share for is USD 122.511 so the ETF has sold 2660 shares on 2025-12-19 at a higher price than the previous selling average. |
| NOVN.SW - | SELL | -2,705 @ CHF 136.357 | CHF -368,846 | The ETF sold 2705 shares of NOVN.SW on 2025-12-19. The shares were previously bought for an average price of CHF 113.545. The shares were sold for 20.1% higher than average price of previous purchases. This sale made a profit of CHF 61,706 The average price that the ETF previously sold NOVN.SW share for is CHF 112.138 so the ETF has sold 2705 shares on 2025-12-19 at a higher price than the previous selling average. |
| HOLX - Hologic Inc | SELL | -4,925 @ USD 74.95 | USD -369,129 | The ETF sold 4925 shares of HOLX on 2025-12-19. The shares were previously bought for an average price of USD 66.2934. The Hologic Inc shares were sold for 13.1% higher than average price of previous purchases. This sale made a profit of USD 42,634 The average price that the ETF previously sold HOLX share for is USD 66.8735 so the ETF has sold 4925 shares on 2025-12-19 at a higher price than the previous selling average. |
| NBIX - Neurocrine Biosciences Inc | SELL | -2,570 @ USD 145 | USD -372,650 | The ETF sold 2570 shares of NBIX on 2025-12-19. The shares were previously bought for an average price of USD 127.74. The Neurocrine Biosciences Inc shares were sold for 13.5% higher than average price of previous purchases. This sale made a profit of USD 44,358 The average price that the ETF previously sold NBIX share for is USD 117.211 so the ETF has sold 2570 shares on 2025-12-19 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -935 @ CHF 408.997 | CHF -382,412 | The ETF sold 935 shares of ROG.SW on 2025-12-19. The shares were previously bought for an average price of CHF 324.411. The shares were sold for 26.1% higher than average price of previous purchases. This sale made a profit of CHF 79,088 The average price that the ETF previously sold ROG.SW share for is CHF 315.299 so the ETF has sold 935 shares on 2025-12-19 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -1,690 @ USD 226.82 | USD -383,326 | The ETF sold 1690 shares of ABBV on 2025-12-19. The shares were previously bought for an average price of USD 201.245. The AbbVie Inc shares were sold for 12.7% higher than average price of previous purchases. This sale made a profit of USD 43,222 The average price that the ETF previously sold ABBV share for is USD 188.045 so the ETF has sold 1690 shares on 2025-12-19 at a higher price than the previous selling average. |
| GSK.L - GlaxoSmithKline PLC | SELL | -15,755 @ GBP 24.3447 | GBP -383,551 | The ETF sold 15755 shares of GSK.L on 2025-12-19. The shares were previously bought for an average price of GBP 19.3589. The GlaxoSmithKline PLC shares were sold for 25.8% higher than average price of previous purchases. This sale made a profit of GBP 78,551 The average price that the ETF previously sold GSK.L share for is GBP 18.5772 so the ETF has sold 15755 shares on 2025-12-19 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -3,945 @ USD 101.09 | USD -398,800 | The ETF sold 3945 shares of MRK on 2025-12-19. The shares were previously bought for an average price of USD 80.8147. The Marks Electrical Group PLC shares were sold for 25.1% higher than average price of previous purchases. This sale made a profit of USD 79,986 The average price that the ETF previously sold MRK share for is USD 88.5706 so the ETF has sold 3945 shares on 2025-12-19 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -3,945 @ USD 101.09 | USD -398,800 | The ETF sold 3945 shares of MRK on 2025-12-19. The shares were previously bought for an average price of USD 80.8147. The Merck & Company Inc shares were sold for 25.1% higher than average price of previous purchases. This sale made a profit of USD 79,986 The average price that the ETF previously sold MRK share for is USD 88.5706 so the ETF has sold 3945 shares on 2025-12-19 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -2,365 @ USD 174.8 | USD -413,402 | The ETF sold 2365 shares of BIIB on 2025-12-19. The shares were previously bought for an average price of USD 130.477. The Biogen Inc shares were sold for 34.0% higher than average price of previous purchases. This sale made a profit of USD 104,824 The average price that the ETF previously sold BIIB share for is USD 142.095 so the ETF has sold 2365 shares on 2025-12-19 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -2,050 @ USD 206.37 | USD -423,059 | The ETF sold 2050 shares of JNJ on 2025-12-19. The shares were previously bought for an average price of USD 170.984. The Johnson & Johnson shares were sold for 20.7% higher than average price of previous purchases. This sale made a profit of USD 72,541 The average price that the ETF previously sold JNJ share for is USD 158.901 so the ETF has sold 2050 shares on 2025-12-19 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -775 @ USD 567.83 | USD -440,068 | The ETF sold 775 shares of TMO on 2025-12-19. The shares were previously bought for an average price of USD 418.499. The Time Out Group plc shares were sold for 35.7% higher than average price of previous purchases. This sale made a profit of USD 115,732 The average price that the ETF previously sold TMO share for is USD 487.506 so the ETF has sold 775 shares on 2025-12-19 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -2,005 @ USD 220.69 | USD -442,483 | The ETF sold 2005 shares of IQV on 2025-12-19. The shares were previously bought for an average price of USD 162.435. The IQVIA Holdings Inc shares were sold for 35.9% higher than average price of previous purchases. This sale made a profit of USD 116,801 The average price that the ETF previously sold IQV share for is USD 179.356 so the ETF has sold 2005 shares on 2025-12-19 at a higher price than the previous selling average. |
| NTRA - Natera Inc | SELL | -1,940 @ USD 231.96 | USD -450,002 | The ETF sold 1940 shares of NTRA on 2025-12-19. The shares were previously bought for an average price of USD 176.324. The Natera Inc shares were sold for 31.6% higher than average price of previous purchases. This sale made a profit of USD 107,934 The average price that the ETF previously sold NTRA share for is USD 165.381 so the ETF has sold 1940 shares on 2025-12-19 at a higher price than the previous selling average. |
| GMAB.CO - | SELL | -1,400 @ DKK 322.581 | DKK -451,613 | The ETF sold 1400 shares of GMAB.CO on 2025-12-19. The shares were previously bought for an average price of DKK 222.447. The shares were sold for 45.0% higher than average price of previous purchases. This sale made a profit of DKK 140,188 The average price that the ETF previously sold GMAB.CO share for is DKK 219.059 so the ETF has sold 1400 shares on 2025-12-19 at a higher price than the previous selling average. |
| UCB.BR - UCB SA | SELL | -1,705 @ EUR 282.445 | EUR -481,569 | The ETF sold 1705 shares of UCB.BR on 2025-12-19. The shares were previously bought for an average price of EUR 208.203. The UCB SA shares were sold for 35.7% higher than average price of previous purchases. This sale made a profit of EUR 126,583 The average price that the ETF previously sold UCB.BR share for is EUR 184.478 so the ETF has sold 1705 shares on 2025-12-19 at a higher price than the previous selling average. |
| ILMN - Illumina Inc | SELL | -3,645 @ USD 134.78 | USD -491,273 | The ETF sold 3645 shares of ILMN on 2025-12-19. The shares were previously bought for an average price of USD 95.299. The Illumina Inc shares were sold for 41.4% higher than average price of previous purchases. This sale made a profit of USD 143,908 The average price that the ETF previously sold ILMN share for is USD 102.892 so the ETF has sold 3645 shares on 2025-12-19 at a higher price than the previous selling average. |
| EXAS - EXACT Sciences Corporation | SELL | -4,920 @ USD 101.82 | USD -500,954 | The ETF sold 4920 shares of EXAS on 2025-12-19. The shares were previously bought for an average price of USD 62.0439. The EXACT Sciences Corporation shares were sold for 64.1% higher than average price of previous purchases. This sale made a profit of USD 195,698 The average price that the ETF previously sold EXAS share for is USD 54.5995 so the ETF has sold 4920 shares on 2025-12-19 at a higher price than the previous selling average. |